Sonire Therapeutics raised $18 million in a Series A financing round to support its high-intensity focused ultrasound (HIFU) ...

A multicenter clinical study in Austria has shown that a new, highly precise ultrasound approach can successfully target and treat early prostate cancer while preserving patients' quality of life.

RIYADH, SAUDI ARABIA, February 24, 2026 /EINPresswire.com/ — King Faisal Specialist Hospital and Research Centre (KFSH) in Riyadh has successfully introduced a ...

Sonablate, a global leader in focused ultrasound technologies, today announced key additions to its leadership team as it scales "precision sound medicine"--using targeted ultrasound energy to treat ...

Four-year outcomes of a genetic-based screening protocol for prostate cancer: Unveiling the Italian paradox. This is an ASCO Meeting Abstract from the 2026 ASCO Genitourinary Cancers Symposium. This ...

Source: Getty Images To date, there is a lack of high-quality data comparing focal therapies to prostate cancer surgery or radiation. Focal therapy is emerging as a standard management strategy for ...

FUS utilizes multiple beams of relatively low-frequency ultrasound (generally within 0.2–3 MHz, depending on the application ...